Influence of Immunogenicity on the Efficacy of Long-Term Treatment with TNFα Blockers in Rheumatoid Arthritis and Spondyloarthritis Patients

Objective. To analyze the clinical relevance of the levels of TNFα blockers and anti-drug antibodies (anti-drug Ab) in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) treated with adalimumab (ADA), etanercept (ETA), or infliximab (INF) for a prolonged period of time. Methods. Cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Arstikyte, Inesa, Kapleryte, Giedre, Butrimiene, Irena, Venalis, Algirdas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427010/
https://www.ncbi.nlm.nih.gov/pubmed/26064930
http://dx.doi.org/10.1155/2015/604872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427010/
https://www.ncbi.nlm.nih.gov/pubmed/26064930
http://dx.doi.org/10.1155/2015/604872

Ejemplares similares